Overview
A convergence of technologies - including gene sequencing, machine learning and advanced imaging techniques – is creating huge opportunity for innovative biotech firms. Investment manager Rose Nguyen tells Intellectual Capital Editor Malcolm Borthwick about some of the companies leading the field.